Events & Conferences

Small Pharma CEO Peter Rand & CMSO Dr Carol Routledge at the 34th Annual Roth Conference

View Small Pharma’s Fireside Chat Webcast from the 34th Annual Roth Conference

Monday, March 14 at 3:30 – 3:55PM/PT

Roth Conference Fireside Chat

Watch the Small Pharma Fireside Chat >

Elemer Piros, Senior Research Analyst at Roth Capitol, hosts Small Pharma’s CEO, Peter Rands, and Chief Medical and Scientific Officer, Dr. Carol Routledge, for a fireside chat. 

The Webcast Video is from Monday, March 14. The conversation lasted 23 minutes, covering a number of topics from the foundation of Small Pharma to the joining of Dr Routledge to a discussion of current clinical trials for DMT-assisted therapy in the treatment of Major Depressive Disorder.

For further information contact: 

Small Pharma

Peter Rands
Chief Executive Officer
Tel: +44 (0)20 7112 9118

Investor Relations Contacts:

Eric Ribner
LifeSci Advisors
Tel: +1 (646)-889-1200

Tim Regan
KCSA Strategic Communications
Tel: +1 (347) 487-6788

Media Relations Contacts:

McKenna Miller
KCSA Strategic Communications
Tel: +1 (949) 949-6585

Rest of World
Donna Curran
Hanover Communications
Tel: +44 (0)20 7400 4480

About Small Pharma

We’re a mental health drug development company that’s accelerating the development of fast acting antidepressant treatments using DMT based therapies. We’re dedicated to making a difference.

Get Small Pharma
Investor Updates

    Investor Deck

    Follow us: